Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 68 | 2024 | 3695 | 6.450 |
Why?
|
Bone Resorption | 21 | 2023 | 722 | 3.870 |
Why?
|
Spondylarthritis | 8 | 2022 | 62 | 3.630 |
Why?
|
Osteoclasts | 23 | 2023 | 729 | 3.200 |
Why?
|
Rheumatology | 14 | 2024 | 576 | 2.800 |
Why?
|
Arthritis, Experimental | 13 | 2016 | 291 | 2.470 |
Why?
|
Synovial Membrane | 19 | 2024 | 506 | 2.350 |
Why?
|
Rheumatic Diseases | 15 | 2023 | 590 | 2.250 |
Why?
|
Bone and Bones | 21 | 2023 | 2575 | 2.170 |
Why?
|
Osteogenesis | 13 | 2023 | 1299 | 2.160 |
Why?
|
Osteoblasts | 14 | 2023 | 1163 | 2.040 |
Why?
|
Endodeoxyribonucleases | 6 | 2020 | 162 | 1.900 |
Why?
|
Arthritis, Psoriatic | 4 | 2024 | 215 | 1.220 |
Why?
|
Teriparatide | 3 | 2020 | 225 | 1.210 |
Why?
|
Toll-Like Receptors | 5 | 2020 | 592 | 1.190 |
Why?
|
Antirheumatic Agents | 11 | 2024 | 1335 | 1.020 |
Why?
|
Inflammation | 19 | 2023 | 10578 | 1.020 |
Why?
|
RANK Ligand | 11 | 2023 | 326 | 0.960 |
Why?
|
Bone Remodeling | 5 | 2016 | 575 | 0.940 |
Why?
|
Interferons | 3 | 2023 | 704 | 0.890 |
Why?
|
Joints | 7 | 2019 | 326 | 0.870 |
Why?
|
Hereditary Autoinflammatory Diseases | 1 | 2022 | 39 | 0.840 |
Why?
|
Interleukin-17 | 3 | 2020 | 900 | 0.820 |
Why?
|
Interleukin-23 | 2 | 2024 | 193 | 0.810 |
Why?
|
Osteoarthritis | 6 | 2024 | 1034 | 0.730 |
Why?
|
Vasculitis | 2 | 2024 | 521 | 0.720 |
Why?
|
Musculoskeletal Diseases | 5 | 2022 | 581 | 0.660 |
Why?
|
Spondylarthropathies | 2 | 2010 | 14 | 0.640 |
Why?
|
Nucleic Acids | 2 | 2020 | 181 | 0.640 |
Why?
|
Membrane Glycoproteins | 10 | 2015 | 3769 | 0.630 |
Why?
|
Signal Transduction | 16 | 2023 | 23387 | 0.620 |
Why?
|
Spondylitis, Ankylosing | 3 | 2020 | 155 | 0.610 |
Why?
|
Cytokines | 13 | 2023 | 7317 | 0.590 |
Why?
|
Periosteum | 2 | 2019 | 138 | 0.570 |
Why?
|
Bone Diseases, Metabolic | 2 | 2017 | 417 | 0.570 |
Why?
|
Bone Morphogenetic Protein 3 | 1 | 2016 | 17 | 0.560 |
Why?
|
RNA, Messenger | 15 | 2016 | 13029 | 0.540 |
Why?
|
Autoimmune Diseases | 4 | 2022 | 2130 | 0.530 |
Why?
|
Societies, Medical | 4 | 2021 | 3740 | 0.530 |
Why?
|
Autoantibodies | 5 | 2022 | 2036 | 0.530 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 9 | 2016 | 79 | 0.520 |
Why?
|
Tumor Necrosis Factor-alpha | 13 | 2020 | 4414 | 0.520 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2024 | 2099 | 0.510 |
Why?
|
Bone Development | 3 | 2017 | 483 | 0.480 |
Why?
|
Bone Density Conservation Agents | 2 | 2020 | 774 | 0.470 |
Why?
|
Fibrin | 3 | 2020 | 506 | 0.470 |
Why?
|
Arthritis | 7 | 2015 | 658 | 0.460 |
Why?
|
Animals | 61 | 2023 | 168561 | 0.460 |
Why?
|
Wnt Proteins | 3 | 2012 | 721 | 0.440 |
Why?
|
RNA | 4 | 2020 | 2747 | 0.440 |
Why?
|
Mice | 43 | 2023 | 81045 | 0.430 |
Why?
|
Receptors, Tumor Necrosis Factor | 8 | 2006 | 595 | 0.430 |
Why?
|
Glycoproteins | 10 | 2009 | 2260 | 0.410 |
Why?
|
Mice, Inbred C57BL | 19 | 2023 | 21821 | 0.400 |
Why?
|
Cell Differentiation | 17 | 2023 | 11470 | 0.380 |
Why?
|
DNA-Binding Proteins | 15 | 2023 | 9639 | 0.370 |
Why?
|
Carrier Proteins | 8 | 2014 | 5019 | 0.370 |
Why?
|
Antibody Formation | 2 | 2014 | 1402 | 0.370 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 807 | 0.370 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2723 | 0.360 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 6 | 2006 | 867 | 0.350 |
Why?
|
Bone Diseases | 2 | 2009 | 416 | 0.340 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1431 | 0.330 |
Why?
|
Humans | 108 | 2024 | 742088 | 0.330 |
Why?
|
Osteoprotegerin | 7 | 2016 | 176 | 0.330 |
Why?
|
Bone Density | 4 | 2017 | 3469 | 0.330 |
Why?
|
Metacarpophalangeal Joint | 2 | 2020 | 82 | 0.320 |
Why?
|
Metalloendopeptidases | 3 | 1996 | 396 | 0.320 |
Why?
|
Collagenases | 3 | 2005 | 228 | 0.310 |
Why?
|
Mice, Knockout | 13 | 2020 | 14554 | 0.310 |
Why?
|
Alternative Splicing | 1 | 2013 | 1118 | 0.310 |
Why?
|
Biological Products | 1 | 2016 | 856 | 0.300 |
Why?
|
Autoimmunity | 4 | 2022 | 1348 | 0.300 |
Why?
|
Membrane Proteins | 6 | 2020 | 7873 | 0.290 |
Why?
|
Osteoporosis | 3 | 2019 | 1581 | 0.290 |
Why?
|
Methotrexate | 2 | 2024 | 1720 | 0.290 |
Why?
|
Synovitis | 3 | 2019 | 209 | 0.280 |
Why?
|
Synovitis, Pigmented Villonodular | 2 | 1997 | 34 | 0.270 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2009 | 386 | 0.270 |
Why?
|
Sialoglycoproteins | 2 | 2004 | 318 | 0.270 |
Why?
|
Advisory Committees | 4 | 2021 | 773 | 0.250 |
Why?
|
Inflammation Mediators | 4 | 2015 | 1889 | 0.250 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9274 | 0.240 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2022 | 1675 | 0.240 |
Why?
|
Telemedicine | 1 | 2021 | 2853 | 0.230 |
Why?
|
X-Ray Microtomography | 3 | 2022 | 428 | 0.230 |
Why?
|
Th1 Cells | 2 | 2019 | 1056 | 0.230 |
Why?
|
MicroRNAs | 2 | 2016 | 3731 | 0.230 |
Why?
|
Histocompatibility Antigens Class II | 5 | 2019 | 1470 | 0.210 |
Why?
|
Macrophages | 7 | 2016 | 5655 | 0.200 |
Why?
|
Acid Phosphatase | 4 | 2012 | 141 | 0.200 |
Why?
|
Neutrophils | 4 | 2022 | 3711 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4751 | 0.200 |
Why?
|
Disease Models, Animal | 11 | 2022 | 18006 | 0.190 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2003 | 282 | 0.190 |
Why?
|
Glucocorticoids | 2 | 2020 | 2107 | 0.190 |
Why?
|
Inflammasomes | 2 | 2016 | 493 | 0.180 |
Why?
|
Lyme Disease | 2 | 1998 | 618 | 0.180 |
Why?
|
Peer Review, Research | 1 | 2003 | 329 | 0.180 |
Why?
|
Polymyositis | 1 | 2000 | 74 | 0.180 |
Why?
|
Finger Joint | 1 | 2020 | 108 | 0.180 |
Why?
|
Amyloidosis | 2 | 2000 | 795 | 0.180 |
Why?
|
In Situ Hybridization | 6 | 2009 | 1950 | 0.180 |
Why?
|
Diphosphonates | 1 | 2004 | 625 | 0.170 |
Why?
|
Gene Expression Profiling | 5 | 2019 | 9410 | 0.170 |
Why?
|
Truth Disclosure | 1 | 2003 | 435 | 0.170 |
Why?
|
Myocarditis | 2 | 1998 | 770 | 0.170 |
Why?
|
Membrane Transport Proteins | 3 | 2020 | 1028 | 0.160 |
Why?
|
NFATC Transcription Factors | 5 | 2016 | 380 | 0.160 |
Why?
|
Interleukin-1 | 5 | 2003 | 1262 | 0.160 |
Why?
|
Blotting, Western | 4 | 2016 | 5180 | 0.160 |
Why?
|
Editorial Policies | 1 | 2003 | 451 | 0.160 |
Why?
|
Conflict of Interest | 1 | 2003 | 542 | 0.160 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10163 | 0.160 |
Why?
|
Mucin-5B | 1 | 2018 | 141 | 0.160 |
Why?
|
Lipopolysaccharides | 4 | 2005 | 2211 | 0.150 |
Why?
|
Ligands | 2 | 2023 | 3293 | 0.150 |
Why?
|
Toll-Like Receptor 7 | 2 | 2015 | 172 | 0.150 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4147 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 251 | 0.150 |
Why?
|
Disclosure | 1 | 2003 | 736 | 0.150 |
Why?
|
Interleukin-4 | 5 | 1998 | 1146 | 0.150 |
Why?
|
Giant Cell Tumors | 1 | 1997 | 99 | 0.140 |
Why?
|
Fenretinide | 1 | 1996 | 12 | 0.140 |
Why?
|
DNA | 4 | 2022 | 7289 | 0.140 |
Why?
|
Knee Joint | 3 | 2013 | 1679 | 0.140 |
Why?
|
Ulna | 1 | 2017 | 133 | 0.140 |
Why?
|
Biological Therapy | 1 | 2018 | 138 | 0.140 |
Why?
|
Congresses as Topic | 1 | 2021 | 764 | 0.140 |
Why?
|
Hand Bones | 1 | 2016 | 13 | 0.140 |
Why?
|
Endosomes | 2 | 2016 | 520 | 0.140 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2016 | 89 | 0.140 |
Why?
|
Familial Mediterranean Fever | 1 | 2016 | 61 | 0.140 |
Why?
|
Male | 38 | 2024 | 349538 | 0.140 |
Why?
|
Polymerase Chain Reaction | 3 | 2016 | 6171 | 0.130 |
Why?
|
Hand Joints | 1 | 2016 | 53 | 0.130 |
Why?
|
Immunologic Factors | 2 | 2023 | 1575 | 0.130 |
Why?
|
NF-kappa B | 4 | 2014 | 2500 | 0.130 |
Why?
|
Toll-Like Receptor 3 | 1 | 2015 | 91 | 0.130 |
Why?
|
Vaccination | 3 | 2022 | 3256 | 0.130 |
Why?
|
Immunohistochemistry | 9 | 2009 | 11363 | 0.130 |
Why?
|
Fibroblasts | 5 | 2019 | 4143 | 0.130 |
Why?
|
Polyarteritis Nodosa | 1 | 1995 | 66 | 0.130 |
Why?
|
Genes, MHC Class II | 3 | 1995 | 458 | 0.130 |
Why?
|
Interleukin-1beta | 3 | 2016 | 972 | 0.130 |
Why?
|
Mycobacterium Infections | 1 | 1995 | 119 | 0.130 |
Why?
|
Toll-Like Receptor 5 | 1 | 2014 | 39 | 0.120 |
Why?
|
Myxoma | 1 | 1995 | 130 | 0.120 |
Why?
|
Female | 41 | 2024 | 379592 | 0.120 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 1994 | 35 | 0.120 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2014 | 42 | 0.120 |
Why?
|
Radius | 1 | 2017 | 422 | 0.120 |
Why?
|
Dependovirus | 1 | 2019 | 706 | 0.120 |
Why?
|
Myeloid Progenitor Cells | 1 | 2014 | 111 | 0.120 |
Why?
|
Radiography | 5 | 2013 | 7010 | 0.120 |
Why?
|
Interferon Regulatory Factors | 1 | 2015 | 270 | 0.120 |
Why?
|
Interferon-gamma | 2 | 2019 | 3199 | 0.120 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2015 | 315 | 0.120 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7276 | 0.120 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 437 | 0.120 |
Why?
|
Transcription Factors | 9 | 2005 | 12164 | 0.120 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4554 | 0.120 |
Why?
|
Delphi Technique | 3 | 2021 | 778 | 0.120 |
Why?
|
Cells, Cultured | 6 | 2016 | 19223 | 0.120 |
Why?
|
Isoenzymes | 3 | 2012 | 1725 | 0.110 |
Why?
|
Muscular Diseases | 2 | 2022 | 557 | 0.110 |
Why?
|
Collagen Type II | 1 | 2014 | 151 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 2011 | 0.110 |
Why?
|
Blood Sedimentation | 1 | 2014 | 231 | 0.110 |
Why?
|
Peritoneum | 1 | 2014 | 226 | 0.110 |
Why?
|
Angiopoietin-1 | 2 | 2004 | 114 | 0.110 |
Why?
|
Flow Cytometry | 3 | 2019 | 5975 | 0.110 |
Why?
|
Posterior Cruciate Ligament | 1 | 2013 | 88 | 0.110 |
Why?
|
Severity of Illness Index | 6 | 2020 | 15530 | 0.110 |
Why?
|
Tendons | 1 | 1997 | 548 | 0.110 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2016 | 838 | 0.110 |
Why?
|
Gene Silencing | 1 | 2019 | 1538 | 0.110 |
Why?
|
Sirolimus | 1 | 2020 | 1562 | 0.110 |
Why?
|
Middle Aged | 30 | 2024 | 213127 | 0.110 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2566 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 944 | 0.110 |
Why?
|
Cathepsins | 3 | 2006 | 239 | 0.110 |
Why?
|
Follistatin-Related Proteins | 1 | 2012 | 48 | 0.110 |
Why?
|
Cartilage | 5 | 2019 | 818 | 0.100 |
Why?
|
Hand | 3 | 2009 | 882 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3130 | 0.100 |
Why?
|
Peritonitis | 1 | 2014 | 365 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3236 | 0.100 |
Why?
|
Respiration | 1 | 2018 | 1645 | 0.100 |
Why?
|
Heart Neoplasms | 1 | 1995 | 374 | 0.100 |
Why?
|
DNA Primers | 3 | 2009 | 2892 | 0.100 |
Why?
|
B-Lymphocytes | 7 | 2023 | 4664 | 0.100 |
Why?
|
Jurkat Cells | 1 | 2013 | 742 | 0.100 |
Why?
|
beta 2-Microglobulin | 1 | 1992 | 315 | 0.100 |
Why?
|
Arthritis, Infectious | 1 | 1995 | 367 | 0.100 |
Why?
|
Skull | 1 | 2016 | 810 | 0.100 |
Why?
|
Cartilage, Articular | 2 | 2013 | 1095 | 0.100 |
Why?
|
Drug Approval | 1 | 2018 | 740 | 0.100 |
Why?
|
Microbial Collagenase | 1 | 1991 | 122 | 0.100 |
Why?
|
Myeloid Cells | 1 | 2015 | 804 | 0.100 |
Why?
|
Aged | 22 | 2023 | 162944 | 0.090 |
Why?
|
Up-Regulation | 4 | 2013 | 4211 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2107 | 0.090 |
Why?
|
Pandemics | 5 | 2021 | 8328 | 0.090 |
Why?
|
Antigens, CD | 4 | 2006 | 4024 | 0.090 |
Why?
|
Autoantigens | 1 | 2014 | 891 | 0.090 |
Why?
|
Stromal Cells | 1 | 2016 | 1353 | 0.090 |
Why?
|
Monocytes | 4 | 2019 | 2593 | 0.090 |
Why?
|
Anterior Cruciate Ligament | 1 | 2013 | 415 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 1995 | 1203 | 0.090 |
Why?
|
Synovial Fluid | 3 | 2018 | 394 | 0.090 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1374 | 0.090 |
Why?
|
Matrix Metalloproteinase 3 | 3 | 1996 | 134 | 0.090 |
Why?
|
Blotting, Northern | 3 | 2003 | 1581 | 0.090 |
Why?
|
Prosthesis-Related Infections | 1 | 1995 | 538 | 0.090 |
Why?
|
Crohn Disease | 2 | 1995 | 2301 | 0.090 |
Why?
|
Hip Prosthesis | 1 | 1995 | 917 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2019 | 8925 | 0.080 |
Why?
|
Gadolinium | 1 | 2014 | 951 | 0.080 |
Why?
|
Bone Regeneration | 1 | 2012 | 427 | 0.080 |
Why?
|
Metacarpal Bones | 1 | 2009 | 73 | 0.080 |
Why?
|
Down-Regulation | 1 | 2016 | 3001 | 0.080 |
Why?
|
Calcification, Physiologic | 1 | 2009 | 169 | 0.080 |
Why?
|
Chondrocytes | 3 | 2018 | 803 | 0.080 |
Why?
|
Aortitis | 1 | 1989 | 73 | 0.080 |
Why?
|
Rats | 2 | 2022 | 24265 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2013 | 1727 | 0.080 |
Why?
|
Blood Vessels | 1 | 2013 | 1124 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2014 | 2713 | 0.080 |
Why?
|
Cathepsin K | 3 | 2006 | 68 | 0.080 |
Why?
|
Transcription, Genetic | 5 | 2004 | 7721 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 3 | 2005 | 4553 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2906 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 1995 | 1983 | 0.070 |
Why?
|
Base Sequence | 6 | 2009 | 12797 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2217 | 0.070 |
Why?
|
Immunity, Innate | 2 | 2016 | 2956 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2017 | 62966 | 0.070 |
Why?
|
Mice, Inbred DBA | 3 | 2014 | 642 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2915 | 0.070 |
Why?
|
Cohort Studies | 5 | 2020 | 40450 | 0.070 |
Why?
|
Spine | 2 | 2009 | 1143 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2013 | 1548 | 0.070 |
Why?
|
Phenotype | 4 | 2023 | 16331 | 0.070 |
Why?
|
Hip Joint | 2 | 2009 | 1002 | 0.070 |
Why?
|
Proteins | 1 | 2000 | 6096 | 0.060 |
Why?
|
Mice, Inbred C3H | 2 | 1998 | 964 | 0.060 |
Why?
|
Osteopontin | 2 | 2004 | 296 | 0.060 |
Why?
|
United States | 9 | 2022 | 69693 | 0.060 |
Why?
|
Gene Expression | 5 | 2019 | 7790 | 0.060 |
Why?
|
Lymphocyte Activation | 3 | 2013 | 5519 | 0.060 |
Why?
|
Prostaglandins | 1 | 2005 | 405 | 0.060 |
Why?
|
Enzyme Induction | 1 | 2005 | 475 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20086 | 0.060 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2005 | 331 | 0.060 |
Why?
|
Osteolysis | 1 | 2006 | 270 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 329 | 0.060 |
Why?
|
Hospitalization | 2 | 2020 | 10232 | 0.060 |
Why?
|
Immunoenzyme Techniques | 3 | 2003 | 1799 | 0.060 |
Why?
|
Collagen | 3 | 2014 | 2684 | 0.060 |
Why?
|
Rheumatoid Factor | 1 | 2024 | 188 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 1 | 2016 | 3381 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2012 | 9735 | 0.060 |
Why?
|
Receptors, Calcitonin | 2 | 2006 | 37 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2013 | 1222 | 0.060 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2002 | 19 | 0.050 |
Why?
|
Culture Techniques | 1 | 2003 | 554 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2023 | 17400 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3766 | 0.050 |
Why?
|
Arthroplasty, Replacement | 1 | 2006 | 336 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2003 | 170 | 0.050 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2006 | 293 | 0.050 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2001 | 59 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 2935 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 4 | 1 | 2000 | 5 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 5 | 1 | 2000 | 7 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6483 | 0.050 |
Why?
|
Nuclear Proteins | 4 | 2005 | 5851 | 0.050 |
Why?
|
Prosthesis Implantation | 1 | 2006 | 641 | 0.050 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2000 | 38 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2000 | 40 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2000 | 50 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2000 | 59 | 0.050 |
Why?
|
Contrast Media | 1 | 2014 | 5295 | 0.050 |
Why?
|
Interleukins | 2 | 2000 | 791 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2000 | 55 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2005 | 286 | 0.050 |
Why?
|
Antibodies | 2 | 2014 | 2459 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 1213 | 0.050 |
Why?
|
Rats, Transgenic | 1 | 2020 | 71 | 0.050 |
Why?
|
Paraneoplastic Syndromes | 1 | 2001 | 150 | 0.050 |
Why?
|
Remission Induction | 2 | 2019 | 2384 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13019 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2000 | 186 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 2 | 2015 | 261 | 0.040 |
Why?
|
Myofibrils | 1 | 2000 | 146 | 0.040 |
Why?
|
Adult | 13 | 2022 | 213712 | 0.040 |
Why?
|
Dermatomyositis | 1 | 2001 | 223 | 0.040 |
Why?
|
Fingers | 2 | 1995 | 514 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2021 | 317 | 0.040 |
Why?
|
Health Surveys | 1 | 2009 | 4030 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2004 | 2049 | 0.040 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2000 | 116 | 0.040 |
Why?
|
Linear Models | 1 | 2009 | 5948 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 3 | 2005 | 318 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2001 | 12958 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 16665 | 0.040 |
Why?
|
Chondrogenesis | 1 | 2000 | 247 | 0.040 |
Why?
|
Imidazoles | 1 | 2004 | 1205 | 0.040 |
Why?
|
Plasma Cells | 1 | 2001 | 592 | 0.040 |
Why?
|
beta Catenin | 1 | 2023 | 1058 | 0.040 |
Why?
|
Vitronectin | 1 | 1997 | 44 | 0.040 |
Why?
|
Triamcinolone Acetonide | 1 | 2018 | 101 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8662 | 0.040 |
Why?
|
Fractures, Bone | 1 | 2009 | 1945 | 0.040 |
Why?
|
Receptors, Parathyroid Hormone | 1 | 1998 | 332 | 0.040 |
Why?
|
Risk Factors | 4 | 2023 | 72145 | 0.040 |
Why?
|
Pilot Projects | 3 | 2019 | 8297 | 0.040 |
Why?
|
Capsid | 1 | 2019 | 436 | 0.040 |
Why?
|
Epitopes | 1 | 2003 | 2569 | 0.040 |
Why?
|
Polyisoprenyl Phosphates | 1 | 2016 | 36 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 408 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 552 | 0.030 |
Why?
|
Heart Valves | 1 | 1998 | 291 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 1998 | 455 | 0.030 |
Why?
|
Biopsy | 3 | 2000 | 6756 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 1988 | 1901 | 0.030 |
Why?
|
Interferon Type I | 1 | 2019 | 542 | 0.030 |
Why?
|
Radiation Chimera | 1 | 2016 | 223 | 0.030 |
Why?
|
Mice, Inbred BALB C | 3 | 2019 | 6382 | 0.030 |
Why?
|
Aorta, Thoracic | 2 | 1994 | 1080 | 0.030 |
Why?
|
NF-kappa B p50 Subunit | 1 | 1995 | 107 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2938 | 0.030 |
Why?
|
Attitude | 1 | 2020 | 772 | 0.030 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2015 | 60 | 0.030 |
Why?
|
Hydroxyurea | 1 | 2016 | 290 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12242 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 221 | 0.030 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2015 | 107 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 1997 | 644 | 0.030 |
Why?
|
Splenomegaly | 1 | 2015 | 190 | 0.030 |
Why?
|
Borrelia burgdorferi Group | 1 | 1995 | 97 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2001 | 1296 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2000 | 1274 | 0.030 |
Why?
|
Mutation | 3 | 2016 | 29717 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 1995 | 275 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2015 | 212 | 0.030 |
Why?
|
Chemotactic Factors | 1 | 1995 | 199 | 0.030 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1995 | 318 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 846 | 0.030 |
Why?
|
Gout | 2 | 1993 | 556 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 923 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 1995 | 198 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2000 | 13655 | 0.030 |
Why?
|
Flagellin | 1 | 2014 | 125 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 1995 | 299 | 0.030 |
Why?
|
Immunoglobulin M | 2 | 1998 | 1538 | 0.030 |
Why?
|
Cryopreservation | 1 | 2018 | 664 | 0.030 |
Why?
|
B-Lymphocyte Subsets | 1 | 1995 | 246 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 1 | 2015 | 354 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1517 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2016 | 582 | 0.030 |
Why?
|
Endocrine Glands | 1 | 1993 | 103 | 0.030 |
Why?
|
Trans-Activators | 1 | 2003 | 2924 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2009 | 13921 | 0.030 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2014 | 156 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1995 | 575 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1835 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21596 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2014 | 718 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 962 | 0.030 |
Why?
|
Disease Progression | 3 | 2004 | 13256 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2005 | 18112 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 262 | 0.030 |
Why?
|
Luciferases | 2 | 2005 | 733 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 452 | 0.030 |
Why?
|
Hydrogels | 1 | 2018 | 723 | 0.030 |
Why?
|
Lymphopenia | 1 | 1995 | 285 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2011 | 7901 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 438 | 0.030 |
Why?
|
Cell Movement | 2 | 2014 | 5212 | 0.030 |
Why?
|
Antigens, CD19 | 1 | 1995 | 379 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 561 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 1995 | 617 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5304 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 1995 | 4379 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2000 | 2513 | 0.030 |
Why?
|
Hindlimb | 1 | 2014 | 505 | 0.030 |
Why?
|
Drug Industry | 1 | 2018 | 744 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2005 | 3920 | 0.030 |
Why?
|
Cycloheximide | 1 | 1991 | 347 | 0.020 |
Why?
|
Knee Prosthesis | 1 | 1995 | 425 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2751 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2016 | 3199 | 0.020 |
Why?
|
Metalloproteins | 1 | 1991 | 100 | 0.020 |
Why?
|
Arthralgia | 1 | 1995 | 456 | 0.020 |
Why?
|
Aged, 80 and over | 6 | 2022 | 57683 | 0.020 |
Why?
|
Leukocytes | 1 | 2019 | 2039 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1655 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1837 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2014 | 836 | 0.020 |
Why?
|
Hip | 1 | 1992 | 257 | 0.020 |
Why?
|
Arthrography | 1 | 2011 | 149 | 0.020 |
Why?
|
Promoter Regions, Genetic | 4 | 2005 | 5867 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2005 | 1547 | 0.020 |
Why?
|
Wrist | 1 | 1992 | 225 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2275 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2014 | 665 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2276 | 0.020 |
Why?
|
Shoulder | 1 | 1992 | 299 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1991 | 1159 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2004 | 12071 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1581 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2450 | 0.020 |
Why?
|
Osteitis | 1 | 2009 | 33 | 0.020 |
Why?
|
Rheumatoid Nodule | 1 | 1989 | 15 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1731 | 0.020 |
Why?
|
Phosphorylation | 2 | 2014 | 8436 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2425 | 0.020 |
Why?
|
Mice, Nude | 2 | 2000 | 3689 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 1995 | 1469 | 0.020 |
Why?
|
Spondylitis | 1 | 1988 | 22 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1158 | 0.020 |
Why?
|
Deoxyribonuclease I | 1 | 1989 | 228 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2183 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1461 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1788 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1989 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1996 | 4929 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2019 | 1457 | 0.020 |
Why?
|
Fever | 1 | 1995 | 1612 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2000 | 2522 | 0.020 |
Why?
|
Cell Line | 4 | 2005 | 15994 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3518 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 1997 | 1864 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3585 | 0.020 |
Why?
|
Arthroscopy | 1 | 1993 | 924 | 0.020 |
Why?
|
Ischemia | 1 | 1995 | 1911 | 0.020 |
Why?
|
Fos-Related Antigen-2 | 1 | 2005 | 15 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 1989 | 645 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2502 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3800 | 0.020 |
Why?
|
Smad1 Protein | 1 | 2005 | 81 | 0.020 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2005 | 103 | 0.020 |
Why?
|
Langerhans Cells | 1 | 1986 | 173 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77098 | 0.020 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 164 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2001 | 4823 | 0.020 |
Why?
|
Cell Cycle | 2 | 2005 | 2964 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2000 | 4933 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1364 | 0.020 |
Why?
|
Liver | 2 | 1998 | 7470 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 24913 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5611 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2022 | 21719 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1726 | 0.010 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2005 | 350 | 0.010 |
Why?
|
Child, Preschool | 1 | 2006 | 40955 | 0.010 |
Why?
|
Spleen | 1 | 1989 | 2359 | 0.010 |
Why?
|
Tarsus, Animal | 1 | 2002 | 5 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2005 | 905 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 2003 | 427 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1994 | 3465 | 0.010 |
Why?
|
Stevens-Johnson Syndrome | 1 | 1986 | 277 | 0.010 |
Why?
|
Cell Division | 2 | 2000 | 4564 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 611 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1991 | 2524 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 317 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2004 | 677 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2000 | 5169 | 0.010 |
Why?
|
Back | 1 | 2001 | 66 | 0.010 |
Why?
|
Myocardium | 1 | 1995 | 4775 | 0.010 |
Why?
|
Forehead | 1 | 2001 | 69 | 0.010 |
Why?
|
Pain Measurement | 1 | 2011 | 3418 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 264 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2924 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12946 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10472 | 0.010 |
Why?
|
Postmenopause | 1 | 2009 | 2461 | 0.010 |
Why?
|
Chemotaxis | 1 | 2004 | 607 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2004 | 572 | 0.010 |
Why?
|
Polyomavirus | 1 | 2001 | 248 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 1844 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2004 | 1723 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1989 | 2968 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 2305 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 357 | 0.010 |
Why?
|
Chimera | 1 | 2001 | 485 | 0.010 |
Why?
|
Immunization, Passive | 1 | 2002 | 625 | 0.010 |
Why?
|
Mitomycin | 1 | 2000 | 259 | 0.010 |
Why?
|
Tibia | 1 | 2005 | 1075 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 35342 | 0.010 |
Why?
|
Femur | 1 | 2005 | 1297 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2011 | 3391 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1980 | 442 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13853 | 0.010 |
Why?
|
Thorax | 1 | 2001 | 547 | 0.010 |
Why?
|
Endopeptidases | 1 | 2002 | 772 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8077 | 0.010 |
Why?
|
Health Status | 1 | 2011 | 4030 | 0.010 |
Why?
|
Child | 1 | 2006 | 77478 | 0.010 |
Why?
|
Adolescent | 1 | 2006 | 85649 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19862 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 2006 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1782 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5892 | 0.010 |
Why?
|
Calcineurin | 1 | 1998 | 226 | 0.010 |
Why?
|
Apoptosis | 2 | 2005 | 9715 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2001 | 1866 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2000 | 824 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2005 | 3504 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53187 | 0.010 |
Why?
|
Time Factors | 2 | 2009 | 40054 | 0.010 |
Why?
|
Antigens | 1 | 2001 | 1462 | 0.010 |
Why?
|
DNA Damage | 1 | 2005 | 2423 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 1097 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 4187 | 0.010 |
Why?
|
Blood Proteins | 1 | 1980 | 1122 | 0.010 |
Why?
|
Binding Sites | 1 | 2004 | 6115 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2000 | 2236 | 0.010 |
Why?
|
Gene Targeting | 1 | 1998 | 880 | 0.010 |
Why?
|
Morphogenesis | 1 | 1998 | 752 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2004 | 3420 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 1993 | 99 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1997 | 1589 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18355 | 0.010 |
Why?
|
Vibrissae | 1 | 1993 | 125 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6313 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2000 | 3557 | 0.010 |
Why?
|
Salivary Glands | 1 | 1993 | 228 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1998 | 1460 | 0.010 |
Why?
|
Tooth | 1 | 1993 | 207 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9387 | 0.010 |
Why?
|
Erythrocytes | 1 | 1980 | 2452 | 0.010 |
Why?
|
Quality of Life | 1 | 2011 | 12730 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1993 | 865 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3770 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2000 | 2542 | 0.010 |
Why?
|
Prochlorperazine | 1 | 1986 | 17 | 0.000 |
Why?
|
Stem Cells | 1 | 2000 | 3563 | 0.000 |
Why?
|
Alleles | 1 | 1998 | 6931 | 0.000 |
Why?
|
Pancreas | 1 | 1993 | 1684 | 0.000 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1990 | 794 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4455 | 0.000 |
Why?
|
Enhancer Elements, Genetic | 1 | 1990 | 1337 | 0.000 |
Why?
|
Epidermis | 1 | 1986 | 527 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2000 | 6347 | 0.000 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 5171 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1980 | 5724 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1993 | 3278 | 0.000 |
Why?
|
Borohydrides | 1 | 1980 | 32 | 0.000 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1986 | 986 | 0.000 |
Why?
|
Models, Genetic | 1 | 1990 | 3493 | 0.000 |
Why?
|
Anemia, Hemolytic | 1 | 1980 | 168 | 0.000 |
Why?
|
Graft vs Host Disease | 1 | 1986 | 2951 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1980 | 1359 | 0.000 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1986 | 2986 | 0.000 |
Why?
|
Pregnancy | 1 | 1993 | 29087 | 0.000 |
Why?
|